Tallinn Children´s Hospital
- Address
- lock Available on a paid plan
Neoplasms Research in Pediatrics
At Tallinn Children´s Hospital, pediatric clinical research is centered on neoplasms, with a strong focus on acute myeloid leukemia in children and adolescents. The trials are designed to improve treatment outcomes, refine disease control, and support safer, more effective care for young patients.
- Studies in pediatric oncology focused on acute myeloid leukemia
- Research targeting FLT3-ITD positive AML and related high-risk disease features
- Trials evaluating whether new treatment approaches can improve minimal residual disease response and overall leukemia control
Current work includes testing a new therapy for children with newly diagnosed AML and assessing whether treatment strategies can improve efficacy, safety, and long-term disease outcomes.
Leukemia Treatment Optimization
Clinical trials at this health care site are also aimed at improving how acute myeloid leukemia is treated in the pediatric setting. The research explores whether adjustments to standard leukemia care can lead to better remission rates and more durable disease control.
- Focus on newly diagnosed pediatric AML with specific genetic features
- Evaluation of treatment strategies for CD33-positive AML and standard-risk patients
- Purpose of the studies: to test treatment effectiveness, improve early anti-leukemic response, and strengthen survival outcomes
The site’s research portfolio reflects a targeted effort to compare and improve chemotherapy-based approaches, with the goal of advancing care for children facing leukemia.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 1 by active trials.
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 44 other sites in Estonia
Therapeutic Area Benchmark — Estonia
Select a therapeutic area to compare against other sites in Estonia.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Estonia
Market Share
Country: Estonia
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in Tallinn Children´s Hospital
lock Showing 1 of 2 trials — the rest is available on a paid plan.
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| Evaluation of Gemtuzumab Ozogamicin and Drug Combination in Pediatric Acute Myeloid Leukemia: A NOPHO-DB-SHIP Consortium Study | Princess Maxima Center For Pediatric Oncology | Phase III | Recruiting | Jul 2023 | — |
IMP list
lock Showing 1 of 13 compounds — the rest is available on a paid plan.
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Cytarabine | 1 | Unknown | 2023-07-14 | 2023-07-14 |
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.